Related Experiment Video
Updated: May 15, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Evaluation of patients with cardiac amyloidosis using echocardiography, ECG and right heart catheterization
Sven-Olof Granstam1, Sara Rosengren, Ola Vedin
1Department of Medical Sciences: Clinical Physiology, Uppsala University, Uppsala, Sweden. Sven-Olof.Granstam@medsci.uu.se
Insights
Cardiac amyloidosis, a heart condition, presents with specific echocardiogram and ECG findings. Early detection through these methods is crucial for timely intervention and improved patient outcomes.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Electrophysiology
Background:
- Cardiac amyloidosis is a progressive infiltrative disease affecting the heart.
- Accurate characterization of cardiac amyloidosis is essential for patient management.
- Biopsy-verified light chain or transthyretin amyloidosis impacts cardiac function.
Purpose of the Study:
- To characterize cardiac amyloidosis using echocardiography, electrocardiogram (ECG), and right heart catheterization (RHC).
- To identify key diagnostic markers for cardiac amyloidosis.
- To evaluate treatment response in a case of cardiac amyloidosis.
Main Methods:
- Retrospective analysis of 14 patients with biopsy-verified cardiac amyloidosis.
- Echocardiography, ECG, and RHC were utilized for patient characterization.
- Assessment of cardiac structure, function, and hemodynamic parameters.
Main Results:
- Patients exhibited heart failure with elevated NT-proBNP, biventricular hypertrophy, and preserved ejection fraction.
- Echocardiography showed low septal é and high E/é ratio, correlating with elevated pulmonary wedge pressure.
- ECG revealed low voltage, abnormal R-progression, ST-T abnormalities, and high incidence of atrial fibrillation.
Conclusions:
- Echocardiography and ECG findings are suggestive of cardiac amyloidosis.
- These diagnostic modalities aid in identifying patients requiring further investigation.
- Treatment with melphalan and dexamethasone showed potential for improving cardiac parameters.
Aims:
To characterize patients with cardiac amyloidosis using echocardiography, electrocardiogram (ECG) and right heart catheterization (RHC).
Methods And Results:
Fourteen patients with biopsy verified light chain or transthyretin cardiac amyloidosis were included. All patients had heart failure with markedly elevated NT-proBNP. Echocardiography demonstrated biventricular hypertrophy, left atrial enlargement and normal to slightly reduced left ventricular ejection fraction. Tissue Doppler septal é was low and median E/é was high. Within 6 months RHC was performed in eight of the patients. The restrictive filling pattern demonstrated by echocardiography corresponded well to median pulmonary wedge pressure (21 mmHg). Systolic pulmonary artery pressure (SPAP) was increased, whereas cardiac output and stroke volume were seen to be decreased with both methods. ECG demonstrated: low voltage (36%), abnormal R-progression (65%), ST-T abnormalities (71%) and high incidence of fibrillation (36%). In addition, a case report following the treatment of melphalan and dexamethasone is presented with improvement of hypertrophy, SPAP, left ventricular mass and é.
Conclusion:
These findings should lead to a suspicion of cardiac amyloidosis and suggest further investigation.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Dysrhythmias V: Evaluating Dysrhythmias
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Cardiac Catheterization III: Left Heart Catheterization
Cardiac Catheterization I: Pre-Procedure Overview

